Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study.
about
Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study.Defining the threshold for too sick for transplant.Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist.Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.Cause and management of muscle wasting in chronic liver disease.The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates.Development and Validation of a Nomogram for Predicting Survival in Patients with Advanced Pancreatic Ductal Adenocarcinoma.Development of a novel frailty index to predict mortality in patients with end-stage liver disease.Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality.Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation.Muscle at Risk: The Multiple Impacts of Ammonia on Sarcopenia and Frailty in Cirrhosis.Reporting functional status in UNOS: The weakness of the Karnofsky Performance Status Scale.Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation (FrAILT) Study.Editorial: Advancing Adoption of Frailty to Improve the Care of Patients with Cirrhosis: Time for a Consensus on a Frailty Index.The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis.Significantly Higher Mortality Following Liver Transplantation Among Patients Aged 70 Years and Older.Evolution of Geriatric Medicine: Midcareer Faculty Continuing the Dialogue.Human bone marrow mesenchymal stem cells suppress the proliferation of hepatic stellate cells by inhibiting the ubiquitination of p27.Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study.Home-based exercise therapy in patients awaiting liver transplantation: protocol for an observational feasibility trial.Physical Frailty after Liver Transplantation.Interventions to improve physical function and prevent adverse events in cirrhosis.A framework to determine when liver transplantation is futileTrends of characteristics and outcomes of donors and recipients of deceased donor liver transplantation in the United States: 1990 to 2013Beta-blockers and physical frailty in patients with end-stage liver disease
P2860
Q31164899-4DA04E01-0AC8-4D51-AC9F-039B85AEED18Q33868592-F7A7567F-978E-4CDE-993E-05307E6F0389Q36673804-4D4BE0B9-B138-4809-B518-1F061E26FEE7Q37629725-B1E210E1-CD40-4D59-8ABF-E77109CB1C37Q38732987-2DF0C5C2-0E3A-4D40-99C4-E98879849672Q38773837-B3886A22-1FCD-4E44-87B9-6A895D4C93F5Q39652211-1216C810-8B7B-4C29-BFD7-9BE353F653C0Q40040061-7E86D1AD-FCD7-49AD-9A8B-BADD58B98324Q40236980-D7C200B8-D38B-43CF-AFD7-B1D18C481DA5Q42337444-43F6FB20-5CA8-40E9-BF71-61A70AE61831Q42339194-6D37B99B-94BB-4E53-900C-462E272C5EF9Q42741031-82EBC041-6C93-4806-9D1F-0117C4449E85Q43418880-C4CC2EFB-1CBD-42BF-B8CB-CF35853BD434Q45013461-79005566-D916-4A12-9FDA-7BE6B1D9906DQ45975169-D7446E70-450D-4E68-BC4A-271F39258846Q46224394-E9AC6EBD-F82F-497D-964C-6EB4D7A2C494Q46489489-035AB312-41BF-42E3-9C00-6A079EBF20D9Q47396134-60990F49-D174-4FDC-B2AC-8428DDEF833CQ47920481-B0423D3F-23A8-44CC-8C90-68E62376D015Q48024864-7BC0B339-F38B-4274-A71A-AFA414EEFF61Q48043212-3B2820E4-C224-4987-990D-29519BDABD41Q48130444-C4695679-B887-4977-95CA-DAD7E8C12621Q48514061-7CCF16DF-6ACA-412E-AFF4-1B0F322A348EQ49585870-85C25347-6388-400F-B81F-A62B76F91778Q50233423-A592AAF9-9FAF-4BCF-B003-7F78E7FC499BQ57302157-5B94BD0A-9E40-4C6B-A151-E107BFFC2AC6Q58754926-90493A70-A4F8-4079-BFFB-9E8404891382Q58760404-8EF42E2A-DE68-4D36-8252-0F2561A6D664
P2860
Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Functional decline in patients ...... ransplantation (FrAILT) study.
@ast
Functional decline in patients ...... ransplantation (FrAILT) study.
@en
type
label
Functional decline in patients ...... ransplantation (FrAILT) study.
@ast
Functional decline in patients ...... ransplantation (FrAILT) study.
@en
prefLabel
Functional decline in patients ...... ransplantation (FrAILT) study.
@ast
Functional decline in patients ...... ransplantation (FrAILT) study.
@en
P2093
P2860
P356
P1433
P1476
Functional decline in patients ...... ransplantation (FrAILT) study.
@en
P2093
Jennifer C Lai
Jennifer L Dodge
Kenneth Covinsky
Sandy Feng
Saunak Sen
P2860
P304
P356
10.1002/HEP.28316
P407
P577
2015-10-30T00:00:00Z